Xuezhikang therapy increases miR-33 expression in patients with low HDL-C levels

Disease Markers

Volumn 2014, Issue , 2014, Pages

  Cao, Ruihua ^a   Bai, Yongyi ^a   Sun, Lan ^b   Zheng, Jin ^a   Zu, Mian ^b   Du, Guanhua ^b   Ye, Ping ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MICRORNA; MICRORNA 33A; MICRORNA 33B; UNCLASSIFIED DRUG; XUEZHIKANG; HERBACEOUS AGENT; MIRN33 MICRORNA, HUMAN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DRUG CAPSULE; DRUG EFFICACY; DYSLIPIDEMIA; FEMALE; GENE EXPRESSION; HUMAN; LIPID METABOLISM; MALE; MICRORNA BLOOD LEVEL; MIDDLE AGED; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BLOOD; DRUG EFFECTS; DYSLIPIDEMIAS; GENETICS;

AGED; CHOLESTEROL, HDL; DRUGS, CHINESE HERBAL; DYSLIPIDEMIAS; FEMALE; GENE EXPRESSION; HUMANS; MALE; MICRORNAS; MIDDLE AGED;

EID: 84893748688     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2014/781780     Document Type: Article

References (16)

1. Gordon D. J., Probstfield J. L., Garrison R. J., Neaton J. D., Castelli W. P., Knoke J. D., Jacobs D. R. Jr., Bangdiwala S., Tyroler H. A., High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989 79 1 8 15 2-s2.0-0024501678 (Pubitemid 19043669)
2. Nissen S. E., Tardif J.-C., Nicholls S. J., Revkin J. H., Shear C. L., Duggan W. T., Ruzyllo W., Bachinsky W. B., Lasala G. P., Tuzcu E. M., Effect of torcetrapib on the progression of coronary atherosclerosis. The New England Journal of Medicine 2007 356 13 1304 1316 2-s2.0-34047106220 10.1056/NEJMoa070635 (Pubitemid 46513296)
3. Boden W. E., Probstfield J. L., Anderson T., Chaitman B. R., Desvignes-Nickens P., Koprowicz K., McBride R., Teo K., Weintraub W., Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. The New England Journal of Medicine 2011 365 24 2255 2267 2-s2.0-84855171302 10.1056/NEJMoa1107579
4. Fernández-Hernando C., Suárez Y., Rayner K. J., Moore K. J., MicroRNAs in lipid metabolism. Current Opinion in Lipidology 2011 22 2 86 92 2-s2.0-79953740452 10.1097/MOL.0b013e3283428d9d
5. Rayner K. J., Suárez Y., Dávalos A., Parathath S., Fitzgerald M. L., Tamehiro N., Fisher E. A., Moore K. J., Fernández- Hernando C., MiR-33 contributes to the regulation of cholesterol homeostasis. Science 2010 328 5985 1570 1573 2-s2.0-77953787211 10.1126/science.1189862
6. Rayner K. J., Esau C. C., Hussain F. N., McDaniel A. L., Marshall S. M., Van Gils J. M., Ray T. D., Sheedy F. J., Goedeke L., Liu X., Khatsenko O. G., Kaimal V., Lees C. J., Fernandez-Hernando C., Fisher E. A., Temel R. E., Moore K. J., Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature 2011 478 7369 404 407 2-s2.0-80054971110 10.1038/nature10486
7. Rayner K. J., Sheedy F. J., Esau C. C., Hussain F. N., Temel R. E., Parathath S., Van Gils J. M., Rayner A. J., Chang A. N., Suarez Y., Fernandez-Hernando C., Fisher E. A., Moore K. J., Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. Journal of Clinical Investigation 2011 121 7 2921 2931 2-s2.0-79960015327 10.1172/JCI57275
8. Fichtlscherer S., Zeiher A. M., Dimmeler S., Circulating MicroRNAs: biomarkers or mediators of cardiovascular diseases? Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 11 2383 2390 2-s2.0-80054942985 10.1161/ATVBAHA.111.226696
9. Lu Z., Kou W., Du B., Wu Y., Zhao S., Brusco O. A., Morgan J. M., Capuzzi D. M., Effect of xuezhikang, an extract from red yeast chinese rice, on coronary events in a Chinese population with previous myocardial infarction. American Journal of Cardiology 2008 101 12 1689 1693 2-s2.0-44749084870 10.1016/j.amjcard.2008.02.056
10. Li J.-J., Hu S.-S., Fang C.-H., Hui R.-T., Miao L.-F., Yang Y.-J., Gao R.-L., Effects of Xuezhikang, an extract of cholestin, on lipid profile and C-reactive protein: a short-term time course study in patients with stable angina. Clinica Chimica Acta 2005 352 1-2 217 224 2-s2.0-11844269827 10.1016/j.cccn.2004.09.026 (Pubitemid 40093874)
11. Small E. M., Olson E. N., Pervasive roles of microRNAs in cardiovascular biology. Nature 2011 469 7330 336 342 2-s2.0-78751660177 10.1038/nature09783
12. Qureshi I. A., Mehler M. F., The emerging role of epigenetics in stroke: II. RNA regulatory circuitry. Archives of Neurology 2010 67 12 1435 1441 2-s2.0-78650112000 10.1001/archneurol.2010.300
13. Mitchell P. S., Parkin R. K., Kroh E. M., Fritz B. R., Wyman S. K., Pogosova-Agadjanyan E. L., Peterson A., Noteboom J., O'Briant K. C., Allen A., Lin D. W., Urban N., Drescher C. W., Knudsen B. S., Stirewalt D. L., Gentleman R., Vessella R. L., Nelson P. S., Martin D. B., Tewari M., Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings of the National Academy of Sciences of the United States of America 2008 105 30 10513 10518 2-s2.0-48749122914 10.1073/pnas.0804549105
14. D'Alessandra Y., Devanna P., Limana F., Straino S., Di Carlo A., Brambilla P. G., Rubino M., Carena M. C., Spazzafumo L., De Simone M., Micheli B., Biglioli P., Achilli F., Martelli F., Maggiolini S., Marenzi G., Pompilio G., Capogrossi M. C., Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. European Heart Journal 2010 31 22 2765 2773 2-s2.0-78549270354 10.1093/eurheartj/ehq167
15. Zampetaki A., Kiechl S., Drozdov I., Willeit P., Mayr U., Prokopi M., Mayr A., Weger S., Oberhollenzer F., Bonora E., Shah A., Willeit J., Mayr M., Plasma MicroRNA profiling reveals loss of endothelial MiR-126 and other MicroRNAs in type 2 diabetes. Circulation Research 2010 107 6 810 817 2-s2.0-77957259803 10.1161/CIRCRESAHA.110.226357
16. Gui J., Tian Y., Wen X., Zhang W., Zhang P., Gao J., Run W., Tian L., Jia X., Gao Y., Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies. Clinical Science 2011 120 5 183 193 2-s2.0-79251638583 10.1042/CS20100297